Contents
pdf Download PDF
pdf Download XML
51 Views
15 Downloads
Share this article
Original Article | Volume 12 Issue 11 (November, 2026) | Pages 277 - 282
Pubertal Pattern in Beta Thalassemia Patients in relation to Serum Ferritin levels in Tertiary Care Centre
 ,
 ,
1
Associate Professor, Department of Pediatrics, Pt.J.N.M. Medical College and associated Dr. B.R.A.M. Hospital, Raipur
2
PG 3rd Year, Department of Pediatrics, Pt.J.N.M. Medical College and associated Dr. B.R.A.M. Hospital, Raipur
3
Assistant Professor, Department of Pediatrics, Pt.J.N.M. Medical College and associated Dr. B.R.A.M. Hospital, Raipur
Under a Creative Commons license
Open Access
Received
Sept. 5, 2026
Revised
Oct. 10, 2026
Accepted
Oct. 28, 2026
Published
Nov. 16, 2026
Abstract
Background: Beta thalassemia major is a chronic transfusion-dependent disorder associated with iron overload, leading to multiple endocrine complications, including delayed puberty. Serum ferritin serves as an important marker of body iron stores and iron overload may may influence pubertal development through its effects on the hypothalamic–pituitary–gonadal axis. Objective: To evaluate the pubertal pattern in children with beta thalassemia and its association with serum ferritin levels. Methods: This cross-sectional observational analytical study was conducted in a tertiary care center over 12 months. A total of 32 patients aged 8–16 years with beta thalassemia were included. Pubertal status was assessed using Sexual Maturity Rating (SMR). Serum ferritin and hormonal parameters (LH, FSH, estradiol, testosterone) were measured. Statistical analysis was performed using appropriate tests, and a p-value <0.05 was considered significant. Results: The majority of participants were males (68.8%). Overall, 45.5% of patients had delayed puberty. Mean serum ferritin level was 2467 ± 1005 ng/ml. Higher ferritin levels were observed in patients with delayed puberty (3202 ± 409 ng/ml) compared to those with normal puberty (2376 ± 1115 ng/ml), though not statistically significant (p=0.14). Serum LH and FSH levels were significantly higher in patients who had attained puberty (p=0.002 and p=0.040, respectively). Conclusion: Delayed puberty is common in beta thalassemia patients and is strongly associated with reduced gonadotropin levels. Although higher serum ferritin levels were observed in delayed puberty, no significant association was found, suggesting that iron overload contributes indirectly to pubertal dysfunction.
Keywords
INTRODUCTION
Beta thalassemia is one of the most common inherited hemoglobin disorders worldwide, particularly prevalent in developing countries. It is characterized by defective synthesis of the β-globin chain, resulting in chronic hemolyticanemia that necessitates regular blood transfusions for survival. While advances in transfusion therapy and iron chelation have significantly improved life expectancy, longterm complications related to iron overload continue to pose major clinical challenges.1 One of the most important endocrine complications in patients with beta thalassemia is delayed or abnormal pubertal development. Puberty is a complex physiological process regulated by the hypothalamic–pituitary–gonadal (HPG) axis, and its proper progression is essential for normal growth, sexual maturation, and psychosocial well-being. In thalassemia patients, repeated blood transfusions lead to progressive iron accumulation in various organs, including endocrine glands such as the pituitary, gonads, and thyroid. Excess iron deposition causes oxidative stress and cellular damage, ultimately resulting in dysfunction of the HPG axis and impaired pubertal progression.2 Serum ferritin is widely used as a surrogate marker for body iron stores and is routinely monitored in thalassemia patients. Elevated serum ferritin levels reflect iron overload and have been strongly associated with endocrine dysfunction, including hypogonadism, delayed puberty, and growth retardation. Several studies have suggested that higher ferritin levels correlate with a greater risk of pubertal delay; however, the relationship between iron overload and pubertal patterns is complex and may be influenced by factors such as age at initiation of transfusion, adequacy of chelation therapy, and overall disease severity.3 Understanding the association between serum ferritin levels and pubertal development is crucial for early identification of at-risk individuals and timely intervention. Early recognition of pubertal abnormalities allows for appropriate hormonal evaluation and management, which can significantly improve quality of life and long-term outcomes in these patients. Despite the clinical importance of this issue, there remains variability in findings across different populations, highlighting the need for further studies.4 Therefore, the present study aims to determine the association between pubertal patterns in patients with beta thalassemia and their serum ferritin levels. By evaluating this relationship, the study seeks to contribute to better clinical understanding and guide strategies for monitoring and managing endocrine complications in thalassemia patients.
MATERIALS AND METHODS
This study was designed as a cross-sectional observational analytical study to evaluate the association between pubertal pattern and serum ferritin levels in patients with beta thalassemia. The study was conducted in the Pediatric Ward and Outpatient Department (OPD) of the Department of Pediatrics, Pt. J.N.M. Medical College and Dr. B.R.A.M. Hospital, Raipur, Chhattisgarh, a tertiary care center. The study was carried out over a period of 12 months after obtaining approval from the Institutional Ethics Committee.The study population included patients diagnosed with beta thalassemia attending the pediatric OPD or admitted to the pediatricward.The sample size was of 32 patients.Approval was obtained from the Institutional Ethics Committee prior to the study Informed written consent/assent was obtained from participants/guardians.The study included patients aged 8-16 years diagnosed with beta thalassemia whose parents/gaurdians provided informed consent/assent.The study excluded patients with hormonal imbalance due to other causes eg. Congenital anomalies,tumors,PCOS and those with other hemolytic anemias eg.sickle cell disease,autoimmune hemolytic anemia and patients with a family history of abnormal pubertal development. Pubertal status was assessed using Sexual Maturity Rating (SMR). Serum ferritin and hormonal parameters (LH, FSH, estradiol, testosterone) were measured. Statistical analysis was performed using appropriate tests, and a p-value <0.05 was considered significant.
RESULTS
A total of 32 subjects aged 8–16 years were included in the study. The majority were males (68.8%), with a male-to-female ratio of approximately 2.2:1. The highest number of participants belonged to the 8-year age group (21.9%), followed by 14 years (15.7%) (Table 1). Assessment of pubertal status using Sexual Maturity Rating (SMR) showed that most subjects were in Stage 1 (56.3%), followed by Stage 2 (21.9%), Stage 3 (15.6%), and Stage 4 (6.3%) (Table 2). Among female subjects (n = 10), menarche had been attained in 30%, while 70% were pre-menarcheal (Table 3). The age of onset of puberty ranged from 11 to 13 years, with the majority (57.1%) attaining puberty at 12 years (Table 4). Overall, 54.5% of subjects had a normal pubertal pattern, while delayed puberty was observed in 45.5%,more common among males(36.4%) as compared to females(9.1%). whereas normal puberty was more frequent among females(36.4%) as compared to males(18.1%) (Table 5). The mean serum ferritin level was 2467 ± 1005 ng/ml. The mean serum LH and FSH levels were 0.805 ± 0.633 mIU/ml and 0.712 ± 0.737 mIU/ml, respectively. Estradiol and testosterone levels showed wide variability among subjects (Table 6). On comparison based on pubertal attainment, serum ferritin levels were higher in subjects who had not attained puberty (2625 ± 908 ng/ml) compared to those who had attained puberty (2262 ± 1118 ng/ml), though the difference was not statistically significant (p = 0.3). However, serum LH and FSH levels were significantly higher in subjects who had attained puberty (p = 0.002 and p = 0.040, respectively) (Table 7). Subjects with delayed puberty had higher mean serum ferritin levels (3202 ± 409 ng/ml) compared to those with normal pubertal development (2376 ± 1115 ng/ml), although this difference was not statistically significant (p = 0.14) (Table 8). Among female subjects, those who had attained menarche had higher mean serum ferritin levels (3321 ± 305 ng/ml) compared to those who had not attained menarche (2840 ± 766 ng/ml), but the difference was not statistically significant (p = 0.2) (Table 9). Table 1: Age and Sex Distribution of Study Subjects (n = 32) Age (years) Male n (%) Female n (%) Total n (%) 8 6 (18.8) 1 (3.1) 7 (21.9) 9 1 (3.1) 1 (3.1) 2 (6.2) 10 3 (9.4) 1 (3.1) 4 (12.5) 11 2 (6.3) 1 (3.1) 3 (9.4) 12 3 (9.4) 1 (3.1) 4 (12.5) 13 1 (3.1) 2 (6.3) 3 (9.4) 14 3 (9.4) 2 (6.3) 5 (15.7) 15 2 (6.3) 0 (0) 2 (6.3) 16 1 (3.1) 1 (3.1) 2 (6.3) Total 22 (68.8) 10 (31.2) 32 (100) Table 2: Distribution According to SMR Stage (n = 32) SMR Stage Male n (%) Female n (%) Total n (%) Stage 1 14 (43.8) 4 (12.5) 18 (56.3) Stage 2 4 (12.5) 3 (9.4) 7 (21.9) Stage 3 4 (12.5) 1 (3.1) 5 (15.6) Stage 4 0 (0) 2 (6.3) 2 (6.3) Total 22 (68.8) 10 (31.2) 32 (100) Table 3: Distribution of Female Subjects According to Menarche (n = 10) Menarche Status Number Percentage (%) Attained 3 30 Not Attained 7 70 Table 4: Age of Onset of Puberty (n = 7) Age (years) Male n (%) Female (%) n Total (%) n 11 1 (14.3) 0 (0) 1 (14.3) 12 1 (14.3) 3 (42.9) 4 (57.1) 13 1 (14.3) 1 (14.3) 2 (28.6) Total 3 (42.9) 4 (57.1) 7 (100) Table 5: Descriptive Statistics of Hormonal and Biochemical Parameters Parameter N Mean ± SD Median (IQR) Range Serum Ferritin (ng/ml) 32 2467 ± 1005 2777 (1531) 237–3844 Serum LH (mIU/ml) 32 0.805 ± 0.633 0.995 (1.25) 0.01–1.92 Serum FSH (mIU/ml) 32 0.712 ± 0.737 0.425 (0.423) 0.20–3.90 Estradiol (pg/ml) 10 47.3 ± 49.0 15.9 (80.5) 10.2–121 Testosterone (ng/dl) 22 29.6 ± 36.4 6.30 (47.5) 3.2–102 Table 6: Comparison of Parameters Based on Pubertal Attainment Parameter Attained (n=14) Not Attained (n=18) Mean Difference 95% CI pvalue Serum Ferritin (ng/ml) 2262 ± 1118 2625 ± 908 -363 -1120 394 to 0.3 Serum LH (mIU/ml) 1.35 (1.01– 1.56) 0.26 (0.03–1.02) — — 0.002 Serum FSH (mIU/ml) 0.55 (0.44– 1.45) 0.40 (0.20–0.51) — — 0.040 Table 7: Comparison of Serum Ferritin with Pubertal Pattern Parameter Delayed (n=5) Normal (n=6) Mean Difference 95% CI p-value Serum (ng/ml) Ferritin 3202 ± 409 2376 1115 ± 826 -351 2003 to 0.14 Table 8: Serum Ferritin and Menarche Status (Females) Parameter Attained (n=3) Not Attained (n=7) Mean Difference 95% CI p-value Serum (ng/ml) Ferritin 3321 ± 305 2840 ± 766 481 -300 to 1262 0.2
DISCUSSION
The present cross-sectional observational study evaluated pubertal patterns in children with βthalassemia major and their association with serum ferritin levels. A total of 32 subjects aged 8–16 years were included, with a predominance of younger age groups and males. Differences in demographic characteristics compared to other studies may influence pubertal and endocrine outcomes. A large proportion of subjects were in the early stages of sexual maturation, indicating delayed pubertal progression. Similar findings have been reported in studies where a majority of thalassemia patients remain in early Tanner stages, reflecting impaired pubertal advance. Among female subjects, most had not attained menarche, supporting delayed sexual maturation. Previous studies have also demonstrated delayed menarche and slower pubertal progression in thalassemia patients, often attributed to chronic illness and iron overload. Nearly half of the study population exhibited delayed puberty, which is consistent with earlier reports showing delayed puberty in approximately 45–53% of patients with β-thalassemia major such as by Nasr et al., 2012.5 Delayed puberty was observed in 14.7% (6.7% Females; 21.1% Males) and 13.2% of patients with thalassemia and SCD (6.9% Females; 20.8% Males), respectively by Duiberg et al, 2026.6 Other studies have reported prevalence ranging from 30% to 70%, indicating that pubertal dysfunction is a common complication in transfusion-dependent thalassemia . Hormonal evaluation in the present study revealed reduced gonadotropin levels, suggesting suppression of the hypothalamic-pituitary-gonadal axis. This finding is supported by studies demonstrating significantly lower LH and FSH levels in thalassemia patients with delayed puberty due to hypogonadotropic hypogonadism . Furthermore, patients who had attained puberty showed significantly higher gonadotropin levels, reinforcing the essential role of these hormones in pubertal development. Although serum ferritin levels were higher in subjects with delayed puberty and in those who had not attained puberty, the differences were not statistically significant. Similar findings have been reported in some studies8,10, where no direct correlation was observed between ferritin levels and pubertal delay . However, other studies have identified serum ferritin as a significant determinant of pubertal arrest, suggesting that iron overload plays an important contributory role.7 This variation indicates that ferritin may act as an indirect marker of cumulative iron toxicity rather than a sole predictor of pubertal dysfunction. .Abeer A Al Tameemi et al.8 included 50 female patients aged 14–24 years. These differences in demographic profile may influence pubertal and hormonal findings.Among female subjects, no significant association was observed between serum ferritin levels and attainment of menarche, although higher values were noted in those who had attained menarche. This inconsistency has also been observed in previous studies, highlighting variability in the relationship between iron overload and reproductive maturation. Similarly, Nita R Sutay et al.9 demonstrated significant associations between hormonal levels and pubertal progression, particularly showing that reduced gonadotropins were linked to delayed puberty. However, Nita R Sutay et al.9 showed delayed menarche with low estrogen levels, and Abeer A Al Tameemi et al. reported high prevalence of amenorrhea, indirectly indicating the effect of iron overload. The underlying pathophysiology of delayed puberty in β-thalassemia is primarily due to iron deposition in the hypothalamus and pituitary gland, leading to impaired secretion of gonadotropins and resulting in hypogonadotropic hypogonadism. Iron overload also induces oxidative stress, contributing to endocrine gland damage and dysfunction. Studies have demonstrated that increased ferritin levels are associated with suppression of gonadotropins and sex hormones, further supporting this mechanism .Nita R Sutay et al. demonstrated hormonal suppression associated with high ferritin levels, while Evi Dewiyanti et al.10 reported endocrine complications in nearly one-third of patients.Abeer A Al Tameemi et al. highlighted clinical manifestations such as amenorrhea and delayed puberty. Oxidative stress due to iron overload further contributes to endocrine gland damage. In conclusion, delayed puberty is highly prevalent in children with β-thalassemia and is strongly associated with reduced gonadotropin levels. Although serum ferritin levels tend to be higher in patients with delayed puberty, no significant association was observed, suggesting that iron overload contributes indirectly to pubertal dysfunction through endocrine suppression rather than a direct linear relationship.
CONCLUSION
The present study demonstrates that delayed puberty is a common and significant complication in children with β-thalassemia major, affecting nearly half of the study population. The findings highlight a strong association between delayed pubertal development and reduced gonadotropin levels, indicating suppression of the hypothalamic-pituitary-gonadal axis as the primary underlying mechanism.Although serum ferritin levels were higher in subjects with delayed puberty and in those who had not attained puberty, the association was not statistically significant. This suggests that while iron overload contributes to endocrine dysfunction, serum ferritin alone may not serve as a reliable independent predictor of pubertal delay. Instead, its effects appear to be mediated through cumulative damage to endocrine organs.The study underscores the importance of regular monitoring of pubertal development and hormonal status in children with β-thalassemia. Early identification of pubertal delay and timely intervention can help improve growth, reproductive health, and overall quality of life in these patients.
REFERENCES
1. Sadiq IZ, Abubakar FS, Usman HS, Abdullahi AD, Ibrahim B, Kastayal BS, et al. Thalassemia: Pathophysiology, Diagnosis, and Advances in Treatment. Thalassemia Reports. 2024 Oct 15;14(4):81-102. doi:10.3390/thalassrep14040010 2. Al-Sanabra OM, Abbas MA, Hazàa AA, Hazà WJ. Endocrine complications in patients with βthalassemia major receiving iron-chelation therapy. Ther Adv Endocrinol Metab. 2025 Nov 17;16. doi:10.1177/20420188251406554 3. Verma G, Chand R, Anjum M, Rastogi D, Sharma N, Verma S, et al. Association of Serum Ferritin With Growth and Endocrine Function in Thalassemia Major Children in North India: An Observational Study. Cureus. 2024 Nov 30;16(11):e74885-90. doi:10.7759/cureus.74885 4. Hammad M, Fardoos S, Shakoor K, Nasir A. Iron Overload and Endocrine Dysfunction in Adults with Transfusion-Dependent Beta-Thalassemia and Growth Retardation: A Correlational Study. Thalassemia Reports. 2026 Mar 11;16(1):5-11. doi:10.3390/thalassrep16010005 5. Nasr MR, Ebrahim NA, Salahedin O. Growth pattern in children with beta-thalassemia major and its relation with serum ferritin, IGF1 and IGFBP3. Journal of Clinical and Experimental Investigations. 2012 Jun 12;3(2). doi:10.5799/ahinjs.01.2012.02.0135 6. Dülberg J, Sanchez C, Burckhardt M ‐A., Alacán Friedrich L, Salow V, Radauer‐Plank A, et al. Pubertal Assessment and Growth in Patients With Hemoglobinopathies: A Longitudinal Multicenter Study on the Association With Ferritin Levels. Eur J Haematol. 2026 Mar 7;116(3):276-89. doi:10.1111/ejh.70075 7. Singh P, Samaddar S, Parakh N, Chandra J, Seth A. Pubertal Development and its Determinants in Adolescents With Transfusion-Dependent Thalassemia. Indian Pediatr. 2021 Jul 26;58(7):635-8. doi:10.1007/s13312-021-2258-7 8. Al Tameemi AA, Al-Khafaji AH, Al-Janabi AA. Menstrual abnormalities and hormonal profile in females with β-thalassemia major. Iraqi J Hematol.2019;8(1):23-29. 9. Sutay N, Karlekar M, Jagtap A. Growth And Puberty In Girls With B-Thalassemia Major And Its Correlation With Chelation Therapy And Serum Ferritin Levels . Annals of International Medical and Dental Research. 2017;3(3):PE16-21. 10. Dewiyanti E, Aditiawati A, Sari DP. Serum ferritin levels and endocrine disorders in children with thalassemia major. PaediatrIndones. 2021 May 28;61(3):125-32. doi:10.14238/pi61.3.2021.125-32
Recommended Articles
Case Report
Sudden-onset kidney impairment in an HIV-positive patient
...
Published: 29/12/2015
Review Article
Prevalence of bone demineralization in HIV-positive patients
...
Published: 29/06/2016
Case Report
Adult pertussis does exist in India– a case report and review of literature
...
Published: 27/06/2017
Research Article
Vitamin D Deficiency in Pediatrics and Its Adult Consequences: An Original Research
...
Published: 02/11/2024
Research Article
Microbial Profile of Chronic Suppurative Otitis Media in a Tertiary Care Setting.
Published: 02/06/2017
Chat on WhatsApp
© Copyright Journal of Contemporary Clinical Practice